Vaccine platforms and delivery at World Vaccine Congress 2027
Mar 8–11, 2027 Washington, DC ~3k attendees Website
28 organizations at World Vaccine Congress 2027 present work in platforms & delivery, led by suppliers and service providers. Between them they bring 20 presentations to the program. Most represented: Boston Children's Hospital, University of Pennsylvania and National University of San Martín. As of Oct 8, 2026.
Format
Top represented
Showing 1–17 of 28 organizations
| Organization | World Vaccine Congress 2027 Attendance |
|---|---|
Boston Children's Hospital Boston, MA | |
Pediatric teaching hospital of Harvard Medical School, home to the Precision Vaccines Program. | Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. Talk Wed Mar 10 09:10 |
University of Pennsylvania Philadelphia, PA | |
Research university whose Perelman School of Medicine pioneered the modified mRNA used in COVID-19 vaccines. | Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. Talk Wed Mar 10 12:30 Talk Thu Mar 11 09:40 |
National University of San Martín San Martín, Argentina | |
Argentine public university whose researchers developed ARVAC, a recombinant protein COVID-19 vaccine. | Talk Wed Mar 10 12:25 |
Akagera Medicines Waltham, MA | |
Developer of liposomal antibacterial drugs for drug-resistant tuberculosis and MRSA, with vaccine candidates for tuberculosis, Lassa fever, HIV, RSV and influenza. | Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. |
Danaher's genomic medicines group, making custom DNA and RNA oligonucleotides, plasmid DNA, mRNA and proteins used in gene therapies and nucleic acid vaccines. | Keynote Tue Mar 9 12:35 Beyond Pandemic Response: Navigating the Next Evolution of Vaccine Science How the RNA and nanoparticle platforms proven in the COVID-19 pandemic could speed new medicines for cancer, rare diseases and personalized treatment. Platforms & delivery |
Mayo Clinic Rochester, MN | |
Academic medical center whose Vaccine Research Group studies how people respond to vaccines and develops new ones. | Chair Tue Mar 9 09:00 Talk Wed Mar 10 17:10 Deep Dive Session: From Vaccine R&D to Pandemic Prevention: What are the Use Cases for Broadly Protective Vaccines? When vaccines that protect against whole virus families could prevent pandemics, how much breadth is achievable, and how modeling guides their use. Chair Thu Mar 11 13:30 |
UK Health Security Agency (UKHSA) London, United Kingdom | |
UK agency that plans for, prevents and responds to health threats, providing scientific and operational leadership nationally and globally. | Booth Exhibiting at Booth 317 |
Vaxart South San Francisco, CA | |
Develops oral vaccines in tablet form, with candidates against COVID-19 and norovirus. | Booth Exhibiting (no floor booth listed) |
Arcturus Therapeutics San Diego, CA | |
Develops self-amplifying mRNA vaccines and mRNA medicines, including a self-amplifying COVID-19 vaccine approved in Japan and Europe. | Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. |
Montani Biotechnologies Morgantown, WV | |
Developer of mRNA immunotherapies delivered in lipid nanoparticles, aimed at personalized cancer treatments and disease-modifying therapies. | Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. |
University of Alberta Edmonton, Canada | |
Public research university in Edmonton, with research in virology and vaccines. | |
USAMRIID Fort Detrick, MD | |
US Army Medical Research Institute of Infectious Diseases, developing medical countermeasures against biological threats. | Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. |
WR Walter Reed Army Institute of Research Silver Spring, MD | |
US Army research institute developing vaccines and drugs against infectious diseases that threaten military personnel. | Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. |
Acuitas Therapeutics Vancouver, Canada | |
Develops lipid nanoparticle (LNP) delivery systems for mRNA vaccines and therapeutics, licensed to partner companies. | Booth Exhibiting (no floor booth listed) |
Drug delivery partner supplying delivery devices, formulation and development services, including nasal delivery, to pharmaceutical companies worldwide. | Booth Exhibiting at Booth 279 |
Croda Snaith, United Kingdom | |
Supplies vaccine adjuvants, lipids for mRNA delivery and high-purity excipients to vaccine and drug developers. | Booth Exhibiting at Booth 319 |
Life science business of Japan's Daicel, selling chromatography columns, reagents, excipients, drug delivery devices and genomic analysis tools. | Booth Exhibiting at Booth 524 |
Instantly find 20 buyers in platforms & delivery
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World Vaccine Congress 2027 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction